G

Genprex
D

GNPX

1.00500
USD
-0.09
(-8.22%)
Market Closed
Volume
4,935
EPS
-8
Div Yield
-
P/E
-0
Market Cap
8,550,608
OverviewSignalsIdeasNews
Related Instruments
    B
    BIOC
    -0.09610
    (-18.27%)
    0.42990 USD
    B
    BNGO
    -0.00920
    (-3.60%)
    0.24620 USD
    C
    CRIS
    -0.04000
    (-1.00%)
    3.96000 USD
    M
    MYOV
    0
    (0%)
    0.000000 USD
    N
    NTRA
    -5.120
    (-3.39%)
    146.040 USD
    P
    PRPO
    -0.30000
    (-4.76%)
    6.00000 USD
    Q
    QDEL
    -2.760
    (-7.08%)
    36.210 USD
    V
    VYNE
    -0.15000
    (-5.28%)
    2.69000 USD
    More
News

Title: Genprex

Sector: Healthcare
Industry: Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.